Substance Use Treatment and Access to Resources (STARS) Project
Launched by UNIVERSITY OF OKLAHOMA · Jun 30, 2020
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The STARS Project is a research study designed to help pregnant women who are dealing with substance use issues, such as drug or alcohol dependence. The study is looking at how different types of support can help these women and their babies. Participants in the study will be randomly assigned to one of two groups: one group will receive treatment at the STAR prenatal clinic along with extra support from a therapist who will visit them at home, while the other group will only receive treatment at the clinic. There is also a control group for women who choose not to participate in the study but still receive care at the clinic.
To be eligible for this study, women must be pregnant and have a substance use problem that occurred during their pregnancy. They should also be able to speak and understand English and live in the Oklahoma City area. Participants can expect to receive personalized support, including up to 12 home visits focused on helping them care for their babies and improve their parenting skills. This study aims to provide valuable insights into how we can better support pregnant women facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pregnant woman with substance abuse issue occurring during pregnancy
- • Eligible for services at the STAR prenatal clinic
- • Speaks/comprehends English
- Exclusion Criteria:
- • Unable to read English at 8th grade comprehension level
- • Those outside of Oklahoma City metropolitan area.
About University Of Oklahoma
The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oklahoma City, Oklahoma, United States
Patients applied
Trial Officials
David Bard, PhD
Principal Investigator
OUHSC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials